Various fertility scientific societies have published pathways and recommendations for COVID-19 screening during fertility treatments. As there is currently very limited research evidence on how to best deliver this screening, it is not surprising that there are noticeable differences between their recommendations. This paper compares the screening pathways recommended by these guidelines, in the light of the emerging evidence. It proposes the more liberal use of viral testing for improving detection of asymptomatic or mildly symptomatic fertility patients. It also argues that a negative test result on symptomatic individuals should not be over-relied upon for allowing the treatment to proceed. In these cases, a low threshold for cancellation may still need to be maintained.

各个生育科学学会已经发表了在生育治疗期间筛查COVID-19的途径和建议。由于目前关于如何最好地进行这种筛查的研究证据非常有限，因此他们的建议之间存在明显差异也就不足为奇了。本文根据新兴证据对这些指南推荐的筛查途径进行了比较。它建议更广泛地使用病毒检测来改善对无症状或轻度有症状的生育力患者的检测。它还认为，不应过度依赖对有症状个体的阴性测试结果以允许进行治疗。在这些情况下，可能仍需要保持较低的取消阈值。